Evidence map›Paper›PMID 30029482›Full record

ReviewNutrients2018

l-Citrulline Supplementation: Impact on Cardiometabolic Health.

Timothy D Allerton, David N Proctor, Jacqueline M Stephens, Tammy R Dugas, Guillaume Spielmann, Brian A Irving

Registry-linked trialOpen access · goldAbstract readReview
In one paragraph

Review in Nutrients, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT07544186 (Effect of a Non-pharmacological Intervention), which is not on this map. Cited by 117 papers, 4 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
117citing papers in PubMed, 4 pooled it
11.1field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT07544186 nacompletednot on this mapstarted 2020, after this paper: background citation

Effect of a Non-pharmacological Intervention (Nutritional Therapy and Pulmonary Rehabilitation) on Endothelial Function, Body Composition, and Physical Functionality in Recovered COVID-19 Patients.

TypeinterventionalSponsorInstituto Nacional de Enfermedades RespiratoriasRan2020 to 2023Enrolled43ConditionsSupplemental Nutrition Assistance Program Education, Post COVID Syndrome, Endothelial FunctionArmsL-citrulline supplementation
3 · Its place in the literature

Who cites it

117 citing papers in PubMed, 4 syntheses or guidelines pooled it, 219 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Trial
  6. Trial
  7. Trial
  8. Trial
  9. The effect of quercetin and citrulline on cycling time trial performance.Journal of the International Society of Sports Nutrition · 2024
    Trial
  10. Trial
  11. Trial
  12. Trial
  13. Trial
  14. Nitric-Oxide-Inducing Factors on Vitamin D Changes in Older People Susceptible to Suffer from Sarcopenia.International journal of environmental research and public health · 2022
    Trial
  15. Trial
  16. Trial
  17. Trial
  18. Trial
  19. Trial
  20. Trial

57 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 1 country.

Timothy D AllertonPennington Biomedical Research Center, Baton Rouge, LA 70808, USA. Timothy.Allerton@pbrc.edu.
David N ProctorDepartment of Kinesiology, Pennsylvania State University, University Park, PA 16802, USA. dnp3@psu.edu.
Jacqueline M StephensPennington Biomedical Research Center, Baton Rouge, LA 70808, USA. jsteph1@lsu.edu.
Tammy R DugasDepartment of Comparative Biomedical Sciences, School of Veterinary Medicine, Louisiana State University, Baton Rouge, LA 70803, USA. tammydugas@lsu.edu.
Guillaume SpielmannPennington Biomedical Research Center, Baton Rouge, LA 70808, USA. gspielmann@lsu.edu.
Brian A IrvingPennington Biomedical Research Center, Baton Rouge, LA 70808, USA. brianairving@lsu.edu.ORCID 0000-0002-4131-9523
Pennington Biomedical Research Center · USLouisiana State University · USPennsylvania State University · US

Funding

Pregnane and Glycosides and Obesity/llya RaskinP50AT002776 · NCCIH · LSU PENNINGTON BIOMEDICAL RESEARCH CTR · PI RIBNICKY, DAVID M · 2005 to 2019
$24.9M
Training in Botanical Approaches to Combat Metabolic SyndromeT32AT004094 · NCCIH · LSU PENNINGTON BIOMEDICAL RESEARCH CTR · PI BRANTLEY, PHILLIP J, STEPHENS, JACQUELINE M · 2009 to 2024
$5.7M
NCCIH NIH HHS P50 AT002776NCCIH NIH HHS T32 AT004094
6 · The paper itself

Abstract

Diminished bioavailability of nitric oxide (NO), the gaseous signaling molecule involved in the regulation of numerous vital biological functions, contributes to the development and progression of multiple age- and lifestyle-related diseases. While l-arginine is the precursor for the synthesis of NO by endothelial-nitric oxide synthase (eNOS), oral l-arginine supplementation is largely ineffective at increasing NO synthesis and/or bioavailability for a variety of reasons. l-citrulline, found in high concentrations in watermelon, is a neutral alpha-amino acid formed by enzymes in the mitochondria that also serves as a substrate for recycling l-arginine. Unlike l-arginine, l-citrulline is not quantitatively extracted from the gastrointestinal tract (i.e., enterocytes) or liver and its supplementation is therefore more effective at increasing l-arginine levels and NO synthesis. Supplementation with l-citrulline has shown promise as a blood pressure lowering intervention (both resting and stress-induced) in adults with pre-/hypertension, with pre-clinical (animal) evidence for atherogenic-endothelial protection. Preliminary evidence is also available for l-citrulline-induced benefits to muscle and metabolic health (via vascular and non-vascular pathways) in susceptible/older populations. In this review, we examine the impact of supplementing this important urea cycle intermediate on cardiovascular and metabolic health outcomes and identify future directions for investigating its therapeutic impact on cardiometabolic health.

Indexed as

Dietary SupplementsEvidence-Based MedicineModels, BiologicalAnimalsAntihypertensive AgentsAnti-Inflammatory Agents, Non-SteroidalAntioxidantsCitrullineDiabetic AngiopathiesEndothelium, VascularHumansHypertensionHypoglycemic AgentsInsulin ResistanceMetabolic SyndromeSarcopeniaAntihypertensive AgentsAnti-Inflammatory Agents, Non-SteroidalAntioxidantsCitrullineHypoglycemic AgentsVasodilator Agentsadipocytesagingargininecardiovascular diseasediabetesendothelial functionenterocytesflow mediated dilationhypertensionimmune cellsinflammationinsulin resistanceinterventionslivermitochondriamusclenitric oxideobesitysupplementstherapeuticswatermelon

Identifiers

PMID30029482
PMCPMC6073798
OpenAlexW2883171854

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.